NCT03675243 (QoLTEM) is a clinical trial of sphincterometry in Transanal Endoscopic Microsurgery (TEM), sponsored by State Scientific Centre of Coloproctology, Russian Federation.

Who is sponsoring NCT03675243?

NCT03675243 is sponsored by State Scientific Centre of Coloproctology, Russian Federation.

What drugs are being tested in NCT03675243?

Interventions in NCT03675243: sphincterometry.

What condition does NCT03675243 study?

NCT03675243 studies Transanal Endoscopic Microsurgery (TEM).

Is NCT03675243 still recruiting?

NCT03675243 is currently completed. Last updated 27 January 2022.

Last reviewed 2022-01-27 · How we verify

NCT03675243: QoLTEM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quality of Life After Transanal Endoscopic Microsurgery (TEM)

Completed Last updated 27 January 2022

What this trial tests

trial testing sphincterometry in Transanal Endoscopic Microsurgery (TEM) in 100 participants. Completed in 30 March 2021.

Timeline

1 April 2018

Primary endpoint
30 March 2020

30 March 2021

Quick facts

Lead sponsor	State Scientific Centre of Coloproctology, Russian Federation
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 April 2018
Primary completion	30 March 2020
Estimated completion	30 March 2021
Sites	1 location across Russia

Drugs / interventions tested

sphincterometry

Conditions studied

Transanal Endoscopic Microsurgery (TEM) — all drugs for Transanal Endoscopic Microsurgery (TEM) →

Sponsor

State Scientific Centre of Coloproctology, Russian Federation — full company profile →

Who can join

Adults 18 to 80, any sex, with Transanal Endoscopic Microsurgery (TEM). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a observational cohort study to determine the influence of Transanal endoscopic microsurgery (TEM) on patients Quality of Life

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Does transanal endoscopic microsurgery affect rectal function?
Khomyakov E, Chernyshov S, Fomenko O, Rybakov E. · · 2023 · cited 2× · PMID 36375444 · DOI 10.3393/ac.2022.00220.0031

Verify or expand the search:

Other State Scientific Centre of Coloproctology, Russian Federation trials

Trials by the same sponsor.

NCT07268261 — Combined Method of Surgical Treatment of Anal Fissure · NA · recruiting
NCT05598164 — Botulinum Toxin Type A in the Treatment of Chronic Anal Fissure · NA · unknown
NCT05495776 — Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer · recruiting
NCT05117697 — Surgical Treatment of a Chronic Anal Fissure · NA · unknown
NCT05228054 — Treatment of Hemorrhoid With 1940nm Laser Procedure · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03675243 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by State Scientific Centre of Coloproctology, Russian Federation
Last refreshed: 27 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03675243.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing